Chawisa Nampoolsuksan

Dr. Chawisa Nampoolsuksan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
VCVitoon Chinswangwatanakul
Vitoon Chinswangwatanakul
AMAsada Methasate
Asada Methasate
JSJirawat Swangsri
Jirawat Swangsri
ATAtthaphorn Trakarnsanga
Atthaphorn Trakarnsanga
TAThawatchai Akaraviputh
Thawatchai Akaraviputh
In the highly contagious coronavirus disease 2019 pandemic, aerosol-generating procedures (AGPs) are associated with high-risk of transmission. Upper gastrointestinal endoscopy is a procedure with the potential to cause dissemination of bodily fluids. At present, there is no consensus that endoscopy is defined as an AGP. This review discusses the current evidence on this topic with additional management. Prevailing publications on coronavirus related to upper gastrointestinal endoscopy and aerosolization from the PubMed and Scopus databases were searched and reviewed. Comparative quantitative analyses showed a significant elevation of particle numbers, implying that aerosols were generated by upper gastrointestinal endoscopy. The associated source events have also been reported. To reduce the dispersion, certain protective measures have been developed. Endoscopic unit protocols are recommended for the concerned personnel. Therefore, upper gastrointestinal endoscopy should be classified as an AGP. Proper practices should be adopted by healthcare workers and patients.

15 June 2020 in Siriraj Medical Journal
Verified
Journal Article
Open access
PDF file
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
TPThammawat Parakonthun
Thammawat Parakonthun
TTThikhamporn Tawantanakorn
Thikhamporn Tawantanakorn
AMAndres Mora
Andres Mora
JSJirawat Swangsri
Jirawat Swangsri
VCVitoon Chinswangwatanakul
Vitoon Chinswangwatanakul
Objective To evaluate short-term postoperative outcomes compared between before and 1 year after the establishment of the Siriraj Upper Gastrointestinal Cancer Center (UGICC). Materials and Methods Medical records of 211 patients who underwent radical gastrectomy at Siriraj Hospital during January 2012-September 2018 were reviewed (before UGICC; B-UGICC). Data of 40 patients operated upon during October 2018-September 2019 were prospectively collected after the establishment of UGICC (A-UGICC). Propensity score (PPS) matched analysis was conducted, and short-term outcomes were compared. Enhanced Recovery After Surgery (ERAS) protocol was applied to some patients in A-UGICC. Results of conventional care (CC) were compared with ERAS protocol. Results PPS matched 78 patients in B-UGICC, and 40 patients in A-UGICC. Median postoperative length of stay (POS) was significantly shorter in A-UGICC than in B-UGICC; however, complications and time to oral diet tolerability were not significantly different between groups. In A-UGICC, median POS and time to toleration of oral diet were significantly shorter among 15 ERAS patients than among 25 CC patients. Intestinal recovery and time to ambulation trended to be earlier in ERAS. 103 CC and 15 ERAS patients were matched to 36 non-ERAS and 13 ERAS patients. Median time to toleration of oral diet was significantly shorter in ERAS than in CC (P<0.001). Median POS was significantly shorter in ERAS (P<0.001). Postoperative complications were non-significantly different between ERAS and CC. There was no mortality in this study. Conclusion UGICC with multidisciplinary team approach contributed to improvement of postoperative short-term outcomes.

10 December 2025 in International Journal of Surgery Open
Verified
Journal Article
Open access
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
TPThammawat Parakonthun
Thammawat Parakonthun
JSJirawat Swangsri
Jirawat Swangsri
AMAsada Methasate
Asada Methasate
Background: Lymph node ratio (LNR) has been considered as a prognostic factor for survival in gastric cancer patients. To date, the best cutoff value with its impact on recurrence has not been identified. Materials and Methods: A total of 100 patients with adenocarcinoma of stomach who underwent curative gastrectomy with lymphadenectomy during 2016–2023 were included in this quaternary care cohort study. The receiver operating characteristic curve followed by calculation of the Youden’s index was used to determine the appropriate LNR. Recurrence-free survival analysis was compared using the cutoff LNR. Cox regression analysis was carried out to identify associating factors. Results: Majority of tumors were poorly differentiated (66%) with 22% of signet ring cell. Pathological stages were T1 21%, T2 14%, T3 34%, and T4 31% with N0 35%, N1 15%, N2 17%, and N3 33%. The median number of total harvested lymph nodes was 41.5 (16–109) with three (0–52) metastatic nodes. A LNR of 0.2 yielded a sensitivity of 83.3% (95%CI 62.6–95.3), a specificity of 82.9% (95%CI 72.5–90.6), and an accuracy of 83% on recurrence. Three-year disease-free survival (DFS) was significantly worse in LNR≥0.2 (32.6% vs 92.8%, P < 0.001) with a median time to recurrence of 18.9 months. Subgroup analysis without N0 cases provided the same sensitivity with a specificity of 68.29% (95%CI 51.91–81.92) and significantly worse 3-year DFS (32.6% vs 83.3%, P < 0.001). From multivariate analysis, pathological N3 stage and LNR≥0.2 were independent factors for recurrence. Conclusion: An LNR of 0.2 may offer the optimal cutoff point to predict gastric cancer recurrence after surgery.

10 November 2025 in Surgeries
Verified
Journal Article
Open access
PDF file
AMAsada Methasate
Asada Methasate
ASAkarawin Sirimongkol
Akarawin Sirimongkol
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
JSJirawat Swangsri
Jirawat Swangsri
TPThammawat Parakonthun
Thammawat Parakonthun
Background/Objectives: To identify independent predictors of free peritoneal cancer cells (FPCC), and to investigate survival outcomes relative to peritoneal cytology status among patients who underwent intended curative gastrectomy for adenocarcinoma of the stomach or esophagogastric junction. Methods: Medical records of patients who underwent radical surgery between January 2005 and December 2020 were retrospectively reviewed. Clinical data and cytology results were evaluated. Multivariate Cox regression analysis was used to identify independent predictors of FPCC. Kaplan–Meier survival analysis was used to estimate disease recurrence and survival outcomes. Results: Out of the 349 enrolled patients, 188 (53.8%) had negative cytology, 32 (9.2%) were positive, and 129 (36.9%) showed atypical cells in peritoneal cytology. Poor differentiation (adjusted odds ratio [aOR]: 2.63, 95% confidence interval [95%CI]: 1.04–6.82; p = 0.015), pT4 (aOR: 4.62, 95%CI: 1.28–14.34; p = 0.018), pN3 (aOR: 4.13, 95%CI: 1.14–15.03; p = 0.031), and metastatic lymph node ratio >0.40 (aOR: 6.49, 95%CI: 1.44–29.14; p = 0.015) were independent predictors of FPCC. Median overall survival was 34.1 months in the negative group, 13.1 months in the positive group, and 28.7 months in the atypical cell group (p < 0.001). Median time to disease recurrence was 20.5, 4.9, and 11.3 months, respectively (p < 0.001). Survival and recurrence outcomes in the atypical cell group were comparable to those with negative cytology. Conclusions: Poorly differentiated histology, pT4, pN3, and metastatic lymph node ratio >0.40 are independent predictors of FPCC, which is significantly associated with poor survival and disease recurrence outcomes. These findings suggest that high-risk patients may benefit from routine peritoneal cytologic screening during surgery to improve risk stratification and guide postoperative treatment planning.

8 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TPThammawat Parakonthun
Thammawat Parakonthun
WRWison Ruangsetakit
Wison Ruangsetakit
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
NSNicha Srisuworanan
Nicha Srisuworanan
ATAtthaphorn Trakarnsanga
Atthaphorn Trakarnsanga
AMAsada Methasate
Asada Methasate
Background and Aims: Traditional guidelines recommend delayed feeding after percutaneous endoscopic gastrostomy (PEG) because of concerns about postprocedural complications. Early feeding is safe after pull-technique PEG; however, optimal timing after push-technique PEG remains uncertain. We evaluated the safety and efficacy of early vs delayed feeding after push-technique PEG, focusing on maximal gastric residual volume, complications, and wound site bacterial colonization. Methods: A randomized noninferiority trial was conducted at a university hospital in 160 patients undergoing successful push-technique PEG placement between February 2022 and June 2023. Patients were randomized 1:1 to early feeding (12 hours). Both groups received identical intermittent drip-feeding protocols. The primary outcome was maximal gastric residual volume. Secondary outcomes were length of stay, opioid consumption, postprocedural complications, and wound culture. Results: Median time to feeding was 2.2 hours (0.7–4.0) in the early group and 17.2 hours (12.8–40.5) in the delayed group. Maximal gastric residual volume did not differ between groups (0 vs 0 mL; P =0.26). Early feeding reduced hospital stay (42.3 vs 46.0 hours; P <0.01) and opioid use (2.0 [0–10] vs 2.0 [0–12] mg; P =0.01). Rates of complications (fever, bleeding, wound infection, abdominal distension) were comparable (20.0% vs 27.5%; P =0.35). Wound cultures showed no significant difference in bacterial colonization (26.3% vs 22.5%; P =0.58). Conclusions: Early enteral feeding within 4 hours after push-technique PEG is safe, does not impair gastric emptying, and reduces hospital stay and opioid use. These findings extend the evidence for early feeding to push-technique procedures. Trial Registration: Thai Clinical Trials Registry. Registration number TCTR20220105003. Web link: https://www.thaiclinicaltrials.org/show/TCTR20220105003 .

30 May 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
TAThawatchai Akaraviputh
Thawatchai Akaraviputh
AMAsada Methasate
Asada Methasate
JSJirawat Swangsri
Jirawat Swangsri
ATAtthaphorn Trakarnsanga
Atthaphorn Trakarnsanga
VCVitoon Chinswangwatanakul
Vitoon Chinswangwatanakul
Background/Aims: The coronavirus disease 2019 pandemic has affected the worldwide practice of upper gastrointestinal endoscopy. Here we designed a modified N95 respirator with a channel for endoscope insertion and evaluated its efficacy in upper gastrointestinal endoscopy.Methods: Thirty patients scheduled for upper gastrointestinal endoscopy were randomized into the modified N95 (n=15) or control (n=15) group. The mask was placed on the patient after anesthesia administration and particles were counted every minute before (baseline) and during the procedure by a TSI AeroTrak particle counter (9306-04; TSI Inc.) and categorized by size (0.3, 0.5, 1, 3, 5, and 10 µm). Differences in particle counts between time points were recorded.Results: During the procedure, the modified N95 group displayed significantly smaller overall particle sizes than the control group (median [interquartile range], 231 [54–385] vs. 579 [213–1,379]×103/m3; p=0.056). However, the intervention group had a significant decrease in 0.3-µm particles (68 [–25–185] vs. 242 [72–588]×103/m3; p=0.045). No adverse events occurred in either group. The device did not cause any inconvenience to the endoscopists or patients.Conclusions: This modified N95 respirator reduced the number of particles, especially 0.3-µm particles, generated during upper gastrointestinal endoscopy.